Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor.

MLA

Lanitis, Evripidis, et al. “Redirected Antitumor Activity of Primary Human Lymphocytes Transduced with a Fully Human Anti-Mesothelin Chimeric Receptor.” Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 20, no. 3, Mar. 2012, pp. 633–43. EBSCOhost, https://doi.org/10.1038/mt.2011.256.

APA

Lanitis, E., Poussin, M., Hagemann, I. S., Coukos, G., Sandaltzopoulos, R., Scholler, N., & Powell, D. J., Jr. (2012). Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor. Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(3), 633–643. https://doi.org/10.1038/mt.2011.256

Chicago

Lanitis, Evripidis, Mathilde Poussin, Ian S Hagemann, George Coukos, Raphael Sandaltzopoulos, Nathalie Scholler, and Daniel J Powell Jr. 2012. “Redirected Antitumor Activity of Primary Human Lymphocytes Transduced with a Fully Human Anti-Mesothelin Chimeric Receptor.” Molecular Therapy : The Journal of the American Society of Gene Therapy 20 (3): 633–43. doi:10.1038/mt.2011.256.